Detalles de la búsqueda
1.
The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
Cancer
; 129(6): 901-907, 2023 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36571512
2.
Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies.
Oncologist
; 28(7): 565-574, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37210568
3.
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
Breast Cancer Res Treat
; 202(1): 191-201, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589839
4.
Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis.
Breast Cancer Res Treat
; 194(3): 597-606, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35715538
5.
Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk-based testing of those older than 60 years.
Cancer
; 127(6): 828-833, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33146899
6.
Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations.
Breast Cancer Res Treat
; 189(3): 641-651, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34417675
7.
A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer.
Breast Cancer Res Treat
; 189(2): 411-423, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34302589
8.
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
Breast Cancer Res Treat
; 189(1): 103-110, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34120223
9.
Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer.
Future Oncol
; 17(34): 4665-4676, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34636255
10.
Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers.
Cancer
; 126(2): 271-280, 2020 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31581314
11.
Medical Management of newly diagnosed breast cancer in a BRCA1/2 mutation carrier.
Breast J
; 26(8): 1506-1512, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32633033
12.
Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
Breast Cancer Res
; 21(1): 107, 2019 09 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31533767
13.
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation.
Br J Cancer
; 121(1): 15-21, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30971774
14.
Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy.
Ann Surg Oncol
; 26(2): 366-371, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30542840
15.
BRCA1/2 testing: therapeutic implications for breast cancer management.
Br J Cancer
; 119(2): 141-152, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29867226
16.
Should We Offer Medication to Reduce Breast Cancer Risk?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
Ann Intern Med
; 165(3): 194-204, 2016 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27479221
17.
The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study.
Br J Cancer
; 114(10): 1160-4, 2016 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26986251
18.
Immediate breast reconstruction following mastectomy in pregnant women with breast cancer.
J Surg Oncol
; 114(2): 140-3, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27392534
19.
Breast cancer screening in the era of density notification legislation: summary of 2014 Massachusetts experience and suggestion of an evidence-based management algorithm by multi-disciplinary expert panel.
Breast Cancer Res Treat
; 153(2): 455-64, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26290416
20.
Sentinel lymph node biopsy in pregnant women with breast cancer.
Ann Surg Oncol
; 21(8): 2506-11, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24756813